Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: 3SBio Inc.

Capitalization 45.9B 52.1B 6.66B 5.82B 5.26B 5.03B 9.15B 616B 9.51B 62.79B 24.88B 294B 24.98B 24.45B 1,062B P/E ratio 2025 *
4.69x
P/E ratio 2026 * 13.6x
Enterprise value 36.11B 40.98B 5.24B 4.58B 4.13B 3.96B 7.19B 484B 7.48B 49.39B 19.57B 231B 19.65B 19.23B 836B EV / Sales 2025 *
1.96x
EV / Sales 2026 * 2.87x
Free-Float
72.15%
Yield 2025 *
3.98%
Yield 2026 * 2.9%
1 day+5.27%
1 week+7.44%
Current month+0.09%
1 month-7.03%
3 months-14.42%
6 months-30.94%
Current year-9.18%
1 week 20.42
Extreme 20.42
22.26
1 month 19.27
Extreme 19.27
24.36
Current year 19.27
Extreme 19.27
29.3
1 year 9.31
Extreme 9.31
36.8
3 years 4.91
Extreme 4.91
36.8
5 years 4.72
Extreme 4.72
36.8
10 years 4.72
Extreme 4.72
36.8
Manager TitleAgeSince
Chief Executive Officer 63 31/12/2005
Director of Finance/CFO - 02/07/2023
Corporate Officer/Principal 56 26/11/2014
Director TitleAgeSince
Chairman 63 02/04/2012
Director/Board Member 56 10/06/2012
Director/Board Member 57 31/05/2015
Change 5d. change 1-year change 3-years change Capi.($)
+5.27%+7.44%+131.65%+180.46% 6.66B
-0.11%-1.85%+11.83%-1.91% 76.53B
-0.24%-2.85%+34.69%+214.04% 54.36B
-2.03%+59.20%+59.20%+59.20% 49.13B
-0.26%-1.10%-43.25%-51.38% 47.5B
-1.81%-1.80%+30.20%-30.80% 26.64B
-1.55%+0.08%+51.82%-64.87% 20.76B
+0.55%-3.54%+36.37%+27.69% 18.42B
+4.02%+2.87%+109.99%+97.42% 17.92B
+0.13%-1.01%+29.62%+51.40% 13.66B
Average +0.41%-1.78%+45.21%+48.13% 33.16B
Weighted average by Cap. -0.27%-1.52%+28.49%+42.07%

Financials

2025 *2026 *
Net sales 18.44B 20.94B 2.67B 2.34B 2.11B 2.02B 3.67B 247B 3.82B 25.23B 10B 118B 10.04B 9.82B 427B 11.49B 13.04B 1.67B 1.46B 1.32B 1.26B 2.29B 154B 2.38B 15.71B 6.23B 73.61B 6.25B 6.12B 266B
Net income 9.59B 10.88B 1.39B 1.22B 1.1B 1.05B 1.91B 129B 1.99B 13.12B 5.2B 61.43B 5.22B 5.11B 222B 3.31B 3.76B 480M 419M 379M 362M 659M 44.37B 685M 4.53B 1.79B 21.2B 1.8B 1.76B 76.57B
Net Debt -9.79B -11.12B -1.42B -1.24B -1.12B -1.07B -1.95B -131B -2.03B -13.4B -5.31B -62.75B -5.33B -5.22B -227B -12.98B -14.73B -1.88B -1.65B -1.49B -1.42B -2.59B -174B -2.69B -17.76B -7.04B -83.18B -7.06B -6.91B -300B
Logo 3SBio Inc.
3SBio Inc is an investment holding company mainly engaged in the development, production, marketing and sale of pharmaceutical products. The Company’s core products include several biopharmaceutical drugs, TPIAO, recombinant human erythropoietin(rhEPO) products, with brand of EPIAO and SEPO, Yisaipu, Cipterbin and a small molecule drug, Mandi and tumor necrosis factor (TNF). Through its subsidiaries, the Company is engaged in project management and consultation. The Company still engages in developing innovative biological products, including mAbs, bi-specific antibodies and fusion proteins, and a number of small molecule drugs, both innovative and generic, in the areas of nephrology, oncology, auto-immune and inflammatory diseases, ophthalmology and dermatological diseases. The Company distributes its products within the domestic market and to overseas markets.
Employees
6,268
Date Price Change Volume
16/03/26 21.96 $ +5.27% 16,161,269
13/03/26 20.86 $ -1.79% 14,718,500
12/03/26 21.24 $ -3.01% 22,868,830
11/03/26 21.90 $ +0.18% 19,766,820
10/03/26 21.86 $ +6.95% 35,932,910
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
13
Last Close Price
18.38CNY
Average target price
34.72CNY
Spread / Average Target
+88.90%

Quarterly revenue - Rate of surprise

SPRING SALE - 40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!
d
:
:
BENEFIT NOW